{
     "PMID": "26657020",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20161017",
     "LR": "20161230",
     "IS": "1873-507X (Electronic) 0031-9384 (Linking)",
     "VI": "155",
     "DP": "2016 Mar 1",
     "TI": "Diphenyl diselenide ameliorates monosodium glutamate induced anxiety-like behavior in rats by modulating hippocampal BDNF-Akt pathway and uptake of GABA and serotonin neurotransmitters.",
     "PG": "1-8",
     "LID": "10.1016/j.physbeh.2015.11.038 [doi] S0031-9384(15)30197-9 [pii]",
     "AB": "UNLABELLED: Monosodium glutamate (MSG), a flavor enhancer used in food, administered to neonatal rats causes neuronal lesions and leads to anxiety when adulthood. AIMS: We investigated the anxiolytic-like effect of diphenyl diselenide (PhSe)2 and its mechanisms on anxiety induced by MSG. MAIN METHODS: Neonatal male and female Wistar rats received a subcutaneous injection of saline (0.9%) or MSG (4 g/kg/day) from the 1st to 10th postnatal day. At 60 days of life, the rats received (PhSe)2 (1mg/kg/day) or vehicle by the intragastric route for 7 days. The spontaneous locomotor activity (LAM), elevated plus maze test (EPM) and contextual fear conditioning test (CFC) as well as neurochemical ([(3)H]GABA and [(3)H]5-HT uptake) and molecular analyses (Akt and p-Akt and BDNF levels) were carried out after treatment with (PhSe)2. KEY FINDINGS: Neonatal exposure to MSG increased all anxiogenic parameters in LAM, EPM and CFC tests. MSG increased GABA and 5-HT uptake in hippocampus of rats, without changing uptake in cerebral cortex. The levels of BDNF and p-Akt were reduced in hippocampus of rats treated with MSG. The administration of (PhSe)2 to rats reversed all behavioral anxiogenic parameters altered by MSG. The increase in hippocampal GABA and 5-HT uptake induced by MSG was reversed by (PhSe)2. (PhSe)2 reversed the reduction in hippocampal BDNF and p-Akt levels induced by MSG. SIGNIFICANCE: In conclusion, the anxiolytic-like action of (PhSe)2 in rats exposed to MSG during their neonatal period is related to its modulation of hippocampal GABA and 5-HT uptake as well as the BDNF-Akt pathway.",
     "CI": [
          "Copyright (c) 2015 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Rosa, Suzan Goncalves",
          "Quines, Caroline Brandao",
          "Stangherlin, Eluza Curte",
          "Nogueira, Cristina Wayne"
     ],
     "AU": [
          "Rosa SG",
          "Quines CB",
          "Stangherlin EC",
          "Nogueira CW"
     ],
     "AD": "Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil. Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil. Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil. Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Centro de Ciencias Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil. Electronic address: criswn@ufsm.br.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151202",
     "PL": "United States",
     "TA": "Physiol Behav",
     "JT": "Physiology & behavior",
     "JID": "0151504",
     "RN": [
          "0 (Anti-Anxiety Agents)",
          "0 (Benzene Derivatives)",
          "0 (Brain-Derived Neurotrophic Factor)",
          "0 (Organoselenium Compounds)",
          "1666-13-3 (diphenyldiselenide)",
          "333DO1RDJY (Serotonin)",
          "56-12-2 (gamma-Aminobutyric Acid)",
          "EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)",
          "W81N5U6R6U (Sodium Glutamate)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Animals, Newborn",
          "Anti-Anxiety Agents/*pharmacology",
          "Anxiety/*chemically induced/*drug therapy/metabolism",
          "Benzene Derivatives/*pharmacology",
          "Brain-Derived Neurotrophic Factor/metabolism",
          "Cerebral Cortex/drug effects/metabolism",
          "Conditioning (Psychology)/drug effects/physiology",
          "Disease Models, Animal",
          "Fear/drug effects/physiology",
          "Female",
          "Hippocampus/*drug effects/metabolism",
          "Male",
          "Motor Activity/drug effects/physiology",
          "Organoselenium Compounds/*pharmacology",
          "Proto-Oncogene Proteins c-akt/metabolism",
          "Rats, Wistar",
          "Serotonin/metabolism",
          "Signal Transduction/drug effects",
          "Sodium Glutamate/*toxicity",
          "gamma-Aminobutyric Acid/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Anxiety",
          "BDNF",
          "Diphenyl diselenide",
          "GABA",
          "Monosodium glutamate",
          "Serotonin"
     ],
     "EDAT": "2015/12/15 06:00",
     "MHDA": "2016/10/19 06:00",
     "CRDT": [
          "2015/12/15 06:00"
     ],
     "PHST": [
          "2015/09/03 00:00 [received]",
          "2015/11/23 00:00 [revised]",
          "2015/11/30 00:00 [accepted]",
          "2015/12/15 06:00 [entrez]",
          "2015/12/15 06:00 [pubmed]",
          "2016/10/19 06:00 [medline]"
     ],
     "AID": [
          "S0031-9384(15)30197-9 [pii]",
          "10.1016/j.physbeh.2015.11.038 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Physiol Behav. 2016 Mar 1;155:1-8. doi: 10.1016/j.physbeh.2015.11.038. Epub 2015 Dec 2.",
     "term": "hippocampus"
}